C-Tritrpticin-C

General Information


DRACP ID  DRACP04116

Peptide Name   C-Tritrpticin-C

Sequence  CVRRFPWWWPFLRRC

Sequence Length  15

UniProt ID  P51524 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C102H142N30O16S2

Absent amino acids  ADEGHIKMNQSTY

Common amino acids  R

Mass  235844

Pl  12.02

Basic residues  4

Acidic residues  0

Hydrophobic residues  7

Net charge  4

Boman Index  -3521

Hydrophobicity  -35.33

Aliphatic Index  45.33

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  16625

Absorbance 280nm  1187.5

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32126228

Title  Selective anticancer activity of Synthetic peptide peptides derived from the host defence peptide tritrpticin

Doi Not available

Year  2020

Literature 2

Pubmed ID 26781579

Title  Cyclic Tritrpticin Analogs with Distinct Biological Activities

Doi Not available

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17182

DRACP is developed by Dr.Zheng's team.